Quiz: There’s a half-truth in this letter that relates to Taylor Crouch’s tenure as CEO of Variagenics, which reverse-merged with Hyseq in 2003 to form Nuvelo; what is the half-truth?
The recent SEC filing by the activist shareholder opposed to the merger (#msg-154143038) undoubtedly played a role in blocking a positive vote—at least for now.